A collaborative cohort of researchers, led by University of Colorado Anschutz Medical Campus professor Angelo D’Alessandro, PhD, have identified kynurenine as a critical new biomarker in the quality of stored red blood cells (RBCs), a crucial step in the development of more personalized transfusions. Study results published today in the journal Blood.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
WASHINGTON — The US has some stockpiles of vaccines for avian flu, FDA’s biologics head Peter Marks said Monday as public health officials raise the alarm over a reported case of avian flu in a […]
Drug pricing and affordability continue to be key issues at both the state and federal levels as new legislation is considered and implementation of legislation that has already passed is underway. This past week, CBSA’s […]
Wells Messersmith, MD, specializes in gastrointestinal (GI) cancers, or cancers of the gut. As the division head of the University of Colorado School of Medicine’s Division of Medical Oncology, Messersmith is pushing the frontiers of […]
Copyright © 2026 Biotech Networks
